Vanda Pharmaceuticals (VNDA) Change in Account Payables (2010 - 2015)
Vanda Pharmaceuticals (VNDA) posted Change in Account Payables of $142000.0 for Q2 2015, down 78.29% sequentially from $654000.0 in Q1 2015, and up 120.14% YoY from $64503.9 in Q2 2014.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Change in Account Payables (2010 - 2015) Analysis & Trends
Vanda Pharmaceuticals has reported Change in Account Payables for 6 years, with the latest figure at $142000.0 in Q2 2015.
- Quarterly Change in Account Payables rose 120.14% year-over-year to $142000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $1.4 million (up 250.49% YoY) and the FY2014 annual result came in at $174000.0, down 53.48% from the prior year.
- Change in Account Payables fell to $142000.0 in Q2 2015 per VNDA's latest filing, from $654000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $909000.0 in Q2 2012 and troughed at -$803000.0 in Q4 2012.
- A 5-year average of $54611.1 and a median of $164000.0 in 2011 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2012 and 2013: Change in Account Payables tumbled 14875.0% in 2012, then soared 482.41% in 2013.
- Over 5 years, Change in Account Payables stood at -$337000.0 in 2011, then plunged by 138.28% to -$803000.0 in 2012, then surged by 136.36% to $292000.0 in 2013, then retreated by 1.37% to $288000.0 in 2014, then sank by 50.69% to $142000.0 in 2015.
- According to Business Quant data, Change in Account Payables over the past three periods registered $142000.0, $654000.0, and $288000.0 for Q2 2015, Q1 2015, and Q4 2014 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Vanda Pharmaceuticals | 327.03 Mn | 157.00 Mn | 46.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 142,000.00 |
| Mar 31, 2015 | 654,000.00 |
| Dec 31, 2014 | 288,000.00 |
| Sep 30, 2014 | 299,000.00 |
| Jun 30, 2014 | -705,000.00 |
| Mar 31, 2014 | 292,000.00 |
| Dec 31, 2013 | 292,000.00 |
| Sep 30, 2013 | -798,000.00 |
| Jun 30, 2013 | 54,000.00 |
| Mar 31, 2013 | 826,000.00 |
| Dec 31, 2012 | -803,000.00 |
| Sep 30, 2012 | -599,000.00 |
| Jun 30, 2012 | 909,000.00 |
| Mar 31, 2012 | -216,000.00 |
| Dec 31, 2011 | -337,000.00 |
| Sep 30, 2011 | -4,000.00 |
| Jun 30, 2011 | 503,000.00 |
| Mar 31, 2011 | 186,000.00 |
| Dec 31, 2010 | 352,000.00 |
| Sep 30, 2010 | -724,000.00 |